Acadia Healthcare Issues Statement with Respect to Government Investigation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Acadia Healthcare (ACHC) PT Lowered to $76 at Barclays Amid Double Digit Percentage Selloff
September 27, 2024 2:29 PM EDTBarclays analyst Andrew Mok lowered the price target on Acadia Healthcare (NASDAQ: ACHC) to $76.00 (from $83.00) while maintaining a Overweight rating.
The analyst comments "Our Thoughts: The developments are clearly negative and prolong an unfavorable cycle of legal, regulatory, and media attention... More



